As precision medicine treatments for cancer continue to evolve and expand, ACCC is committed to providing our members with the latest information, resources, and programs to better assist their patients with critical care decisions.
Precision medicine is personalized medicine based on a patient’s genomics, lifestyle, and environment. These targeted therapies can include bispecific antibodies, biosimilar drugs, and immunotherapy. However, there are many factors to consider when determining which type of cancer treatment is the right choice for a patient and their family. For that reason, ACCC has launched a number of initiatives to ensure that our members have the latest resources to allow them to adapt and respond to any new or evolving treatments in cancer care.
